<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate whether mutation in the exon 10 of the fibroblast growth factor receptor 3(FGFR3) gene in common in Chinese patients with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Genomic DNA from seven <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases of <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> was studied by using PCR-SSCP and restriction enzymes </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> patients carried the same glycine-to-arginine mutation at codon 380(G380R) of the transmembrane domain of FGFR3 </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSION: The results suggest that the G380R mutation of FGFR3 is also a frequent mutation causing <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> in Chinese </plain></SENT>
<SENT sid="4" pm="."><plain>Detecting FGFR 3 gene mutation with PCR-SSCP and restriction enzymes analysis is a convenient, rapid and reliable molecular diagnostic assay for prenatal and early diagnosis of <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
</text></document>